deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT03116984

A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC (TACE-EBRT)

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for HCC Which is Unresectable But Confined to the Liver

Sponsor: 309th Hospital of Chinese People's Liberation Army

Conditions Hepatocellular Carcinoma
Interventions External- beam radiotherapy Transcatheter arterial chemoembolization
Updated 14 times since 2017 Last updated: Apr 8, 2020 Started: Jan 1, 2017 Primary completion: Dec 30, 2020 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03116984, this PHASE3 trial focuses on Hepatocellular Carcinoma and remains ongoing. Sponsored by 309th Hospital of Chinese People's Liberation Army, it has been updated 14 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Aug 2019 · 10 months · monthly snapshot~Aug 2019 – ~May 2020 · 9 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Nov 2022 · 6 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Jul 2023 · 5 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – present · 11 months · monthly snapshot

Change History

14 versions recorded

  1. Aug 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Aug 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  4. Jul 2023 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Feb 2023 — Jul 2023 [monthly]

    Unknown Status PHASE3

▶ Show 9 earlier versions

  1. Nov 2022 — Feb 2023 [monthly]

    Unknown Status PHASE3

  2. May 2022 — Nov 2022 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  3. Jan 2021 — May 2022 [monthly]

    Recruiting PHASE3

  4. May 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  5. Aug 2019 — May 2020 [monthly]

    Recruiting PHASE3

  6. Oct 2018 — Aug 2019 [monthly]

    Recruiting PHASE3

  7. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE3

  8. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  9. Jun 2017 — Dec 2017 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • 309th Hospital of Chinese People's Liberation Army
  • Affiliated Zhongshan Hospital of Dalian University
  • Anhui Provincial Hospital
  • Changhai Hospital
  • Chinese PLA General Hospital
  • First Affiliated Hospital of Fujian Medical University
  • First Affiliated Hospital of Guangxi Medical University
  • First Affiliated Hospital of Xinjiang Medical University
  • First Affiliated Hospital of Zhejiang University
  • First Affiliated Hospital, Sun Yat-Sen University
  • Fudan University
  • Fujian Cancer Hospital
  • Fujian Medical University Union Hospital
  • Heilongjiang Provincial Agricultural Reclamation General Hospital
  • Jilin University
  • Longyan First Hospital, Affiliated to Fujian Medical University
  • Nanfang Hospital, Southern Medical University
  • Peking University Cancer Hospital & Institute
  • Peking University First Hospital
  • Qingdao University
  • Shandong Cancer Hospital and Institute
  • Shanghai 10th People's Hospital
  • Shanghai East Hospital,Tongji University School of Medicine
  • Shanghai Zhongshan Hospital
  • Sichuan Cancer Hospital and Research Institute
  • Subei People's Hospital of Jiangsu Province,Yangzhou University
  • The 4th People's Hospital of Linfen City
  • The 4th people's hospital of Wuxi City, Affiliated to Jiangnan University
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
  • The People's Hospital of Hunan Province
  • The Second Affiliated Hospital of Chongqing Medical University
  • The Third Affiliated Hospital of Qiqihar Medical Universitiy
  • West China Hospital
  • Xinqiao Hospital of Chongqing
  • Yunnan Cancer Hospital
  • Zhongshan Hospital Xiamen University
Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations